Common Contracts
1 similar Global Collaboration Agreement contracts
Halozyme, Ventana global agreement, 7/15Global Collaboration Agreement • December 5th, 2021
The Ventana assay will be used to identify high levels of hyaluronan, or HA, a glycosaminoglycan that can accumulate around cancer cells. Halozyme announced plans for a rollout of a global phase three clinical study in 2016 targeting metastatic pancreatic cancer patients with high HA levels using its PEGPH20 in combination with Abraxane (nab- paclitaxel) and gemcitabine.
